The treatment of Wilms' tumour: results of the United Kingdom Children's Cancer Study Group (UKCCSG) second Wilms' tumour study

被引:0
作者
C Mitchell
P Morris Jones
A Kelsey
G M Vujanic
B Marsden
R Shannon
P Gornall
C Owens
R Taylor
J Imeson
H Middleton
J Pritchard
机构
[1] Paediatric Oncology,Department of Histopathology
[2] Oxford Radcliffe Hospital,Department of Surgery
[3] Royal Manchester Children's Hospital,Department of Radiology
[4] University of Wales College of Medicine,undefined
[5] Paediatric Oncology,undefined
[6] Leicester Royal Infirmary,undefined
[7] Birmingham Children's Hospital,undefined
[8] Great Ormond Street Hospital for Children,undefined
[9] Cookridge Hospital,undefined
[10] UKCCSG Data Centre,undefined
[11] University of Leicester,undefined
[12] Institute of Child Health,undefined
来源
British Journal of Cancer | 2000年 / 83卷
关键词
Wilms'; tumour; treatment; chemotherapy; radiotherapy; childhood cancer;
D O I
暂无
中图分类号
学科分类号
摘要
The aims of the UKW2 study were: (1) to further refine treatment for stage I and II favourable histology (FH) patients; (2) to consolidate the UKW1 results for stage III FH patients; (3) to improve the outlook for patients with inoperable primary tumours and those patients with stage IV and unfavourable histology disease. Treatment consisted of primary nephrectomy, wherever possible, followed by chemotherapy and radiotherapy, as dictated by stage and histology. Treatment was refined successfully for stage I and II FH patients. The 4-year event-free survival for these two groups was 94% and 91%, respectively. Stage III FH patients had a 4-year event free survival of 84%. The outlook for patients with clear cell sarcoma of the kidney is as good as for patients with favourable histology, whilst that for patients with anaplastic or rhabdoid variants remains poor. The outlook for the majority of children with Wilms’ tumour is now excellent. © 2000 Cancer Research Campaign
引用
收藏
页码:602 / 608
页数:6
相关论文
共 150 条
  • [1] Brennan P(1992)Statistical methods for assessing observer variability in clinical measures BMJ 304 1491-1494
  • [2] Silman A(1976)The treatment of Wilms’ tumour. Results of the first National Wilms’ tumour study Cancer 38 633-646
  • [3] D’Angio GJ(1981)The treatment of Wilms’ tumour: results of the second National Wilms’ tumour study Cancer 47 2302-2311
  • [4] Evans AE(1989)The treatment of Wilms’ tumour. Results of the third National Wilms’ tumour study Cancer 64 349-360
  • [5] Breslow N(1990)Wilms’ tumour with pulmonary metastases at diagnosis: The significance of primary chemotherapy J Clin Oncol 8 1187-1190
  • [6] Beckwith B(1999)The role of preoperative chemotherapy in the treatment of nephroblastoma: the SIOP experience Semin Urol Oncol 17 28-32
  • [7] Bishop H(1995)Future directions in clinical research in Wilms’ tumor Hematol Oncol Clin North Am 9 1329-1339
  • [8] Feigl P(1988)Severe hepatic toxicity after treatment with single-dose dactinomycin and vincristine Cancer 62 270-273
  • [9] Goodwin W(1995)Relationship between dose schedule and charges for treatment on national Wilms’ tumor study 4. A report from the National Wilms’ Tumor Study Group J Natl Cancer Inst 19 21-25
  • [10] Leape LL(1996)Wilms’ Tumor CA Cancer J Clin 46 46-63